-
Chinese medical journal · Dec 2020
Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation: a single-center analysis.
- Si-Si Chen, Qian Sun, Lan Cao, Wen-Zhong Wu, Yue Xie, Chun Qiao, Jian-Yong Li, Si-Xuan Qian, and Ming Hong.
- Department of Hematology,The Affiliated Yixing Hospital of Jiangsu University, Wuxi, Jiangsu 214200, China.
- Chin. Med. J. 2020 Dec 8; 134 (12): 147714791477-1479.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?